1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Single Use Assemblies Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising focus of economies in biosimilar development
5.1.1.2. Rising expansion of the pharmaceutical sector with private and public investments
5.1.2. Restraints
5.1.2.1. Issues related to the disposal of waste upon filtering and production scalability
5.1.3. Opportunities
5.1.3.1. Continuous advancements and improvements in single-use assemblies
5.1.3.2. Increasing development and usage of customized single use assemblies
5.1.4. Challenges
5.1.4.1. Concerns pertinent to leachables and extractables
5.2. Market Segmentation Analysis
5.2.1. Product: Development of single use filtration assemblies in reducing cross-contamination risks and faster turnaround times
5.2.2. Solution: Standard solutions offering accessible and cost-effective alternative for mainstream production processes
5.2.3. Application: Increasing demand for single use assemblies in cell culture & mixing to boost vaccine development
5.2.4. End User: Integrating single use assemblies across contract research organizations for quicker processing and process changeover time
5.3. Market Trend Analysis
5.3.1. Availability of patents and expansion of single-use assemblies product portfolios in the Americas
5.3.2. Expansion of the pharmaceutical industry with increasing single-use assemblies’ production facilities in the Asia-Pacific region
5.3.3. Presence of significant native market vendors with increasing research & development activities to introduce novel single use assemblies in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Single Use Assemblies Market, by Product
6.1. Introduction
6.2. Bag Assemblies
6.3. Bottle Assemblies
6.4. Filtration Assemblies
6.5. Mixing System Assemblies
7. Single Use Assemblies Market, by Solution
7.1. Introduction
7.2. Customized Solutions
7.3. Standard Solutions
8. Single Use Assemblies Market, by Application
8.1. Introduction
8.2. Cell Culture & Mixing
8.3. Fill-finish Applications
8.4. Filtration
8.5. Sampling
8.6. Storage
9. Single Use Assemblies Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biopharmaceutical & Pharmaceutical Companies
9.4. Contract Research Organizations & Contract Manufacturing Organizations
10. Americas Single Use Assemblies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Single Use Assemblies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Single Use Assemblies Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
13.3.1.2. Getinge AB to Acquire High Purity New England, Inc., a Provider of Single-use Solutions for Bioprocessing Applications
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Qosina Adds OneShot Single-Use Filling Needles from Overlook Industries to Its Bioprocess Components Portfolio
13.3.2.2. Sartorius and Repligen Launch Upstream Processing Intensification System
13.3.2.3. Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus Auto-Injector
13.3.3. New Product Launch & Enhancement
13.3.3.1. Trelleborg Launches BioPharmaPro Product Line
13.3.3.2. AdvantaPure Launches Single Use Solution for Tubing Management
13.3.3.3. Merck KGaA Launches Ultimus Film to Offer Superior Strength and Leak Resistance in Single-use Assemblies
13.3.4. Investment & Funding
13.3.4.1. U.S.-based Foxx Life Sciences to Invest INR 200 Crore in Telangana
13.3.4.2. Merck Invests More than Euro 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Thermo Fisher Scientific, Inc. Expands Single-Use Technology in China
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 3M Company
14.1.2. Accuflow Systems, Inc.
14.1.3. AdvantaPure by NewAge Industries, Inc.
14.1.4. Ami Polymer Pvt. Ltd.
14.1.5. Antylia Scientific
14.1.6. Avantor, Inc.
14.1.7. avintos AG
14.1.8. BioProcess Engineering Services Limited
14.1.9. BioPulse Solutions Pvt. Ltd.
14.1.10. Cellexus Limited
14.1.11. Cobetter Filtration Group
14.1.12. Colly Flowtech AB
14.1.13. Compagnie de Saint-Gobain S.A.
14.1.14. Corning Incorporated
14.1.15. Danaher Corporation
14.1.16. Distek, Inc.
14.1.17. Dover Corporation
14.1.18. DrM, Dr. Mueller AG
14.1.19. DuPont de Nemours, Inc.
14.1.20. DWK Life Sciences GmbH
14.1.21. Entegris, Inc.
14.1.22. Foxx Life Sciences
14.1.23. GE HealthCare Technologies Inc.
14.1.24. Getinge AB
14.1.25. ILC Dover LP
14.1.26. Intellitech, Inc.
14.1.27. Keofitt A/S
14.1.28. Liquidyne Process Technologies, Inc
14.1.29. Lonza Group Ltd.
14.1.30. Meissner Corporation
14.1.31. Merck KGaA
14.1.32. Owen Mumford Limited
14.1.33. Parker-Hannifin Corporation
14.1.34. Pharsol Ltd.
14.1.35. Purity One
14.1.36. Repligen Corporation
14.1.37. Romynox B.V.
14.1.38. SaniSure Inc.
14.1.39. Sartorius AG
14.1.40. Satake Multimix Corporation
14.1.41. Single Use Support GmbH
14.1.42. Thermo Fisher Scientific Inc.
14.1.43. Trelleborg AB
14.1.44. WHK BioSystems, LLC
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer